Renaissance Technologies - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 11 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$4,420,000
+15.5%
19,200,435
+79.4%
0.01%0.0%
Q4 2021$3,827,000
+5.4%
10,699,831
+77.2%
0.01%0.0%
Q3 2021$3,630,000
-54.6%
6,038,664
-16.2%
0.01%
-50.0%
Q2 2021$7,996,000
-26.1%
7,203,677
-14.8%
0.01%
-23.1%
Q1 2021$10,822,000
+5813.7%
8,454,364
+3017.8%
0.01%
Q4 2020$183,000
-15.7%
271,164
-11.2%
0.00%
Q1 2020$217,000
-42.1%
305,532
-4.6%
0.00%
Q4 2019$375,000320,2250.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2019
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders